West Pharmaceutical Services Inc Initiation

William Blair & Company initiated research coverage of West Pharmaceutical Services, Inc. (WST $111.64), a leading global designer and manufacturer of technologically advanced containment and delivery systems for injectable medicines.

Elanco Animal Health Incorporated

Mayville Engineering Company, Inc Initiation

William Blair & Company initiated research coverage of Mayville Engineering Company, Inc. (MEC $16.30), a leading U.S. contract manufacturer that provides a broad range of prototyping and tooling, production fabrication, coating, assembly, and aftermarket components.

Jeffrey T. Golden

View biography for Jeffrey T. Golden, Managing Director, Wealth Advisor.

Robert J. Duwa

View biography for Robert J. Duwa, CFA, Partner, Head of Global Distribution.

Berkeley Lights Inc Initiation

William Blair & Company initiated research coverage of Berkeley Lights, Inc. (BLI $57.55), a digital cell biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and cell-based products by providing the most advanced environment for rapid functional characterization of single cells at scale.

The Quarterly Rx Q3 2024 US Biopharma Recap

The biopharma sector got a much-needed shot in the arm with the Federal Reserve’s highly anticipated rate cut in September, the first since March 2020.

Greenwich Survey 2020

William Blair, a premier global boutique with expertise in investment banking, investment management, and private wealth management, recently announced results in the Greenwich Associates annual survey of small- and midcap portfolio managers which includes six No. 1 rankings.

U.S. Marine Officer Speaks at Veterans Day Event

U.S. Marine Maj. Thomas Schueman, who spent months working to evacuate an Afghan interpreter who aided his platoon, inspired colleagues with his patriotism and commitment to service at William Blair’s Veterans Day celebration.

The Stock Market and the Election Cycle

In this week’s Economics Weekly, we revisit the cycle, looking at what’s happened during the Trump years relative to history, what we might look forward to in year four (2020), and what might happen if President Trump is elected for a second term in office.